5 completed. 5 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 5 |
| Phase 1 | 2 | Completed 2 |
Follow Biliary Atresia: new trials by email Literature Review of Biliary Atresia trials Research Report on Biliary Atresia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Maralixibat in Biliary Atresia Response Post-Kasai Maralixibat, Placebo - Biliary Atresia | Phase 2 | Completed | Mirum Pharmaceuticals, Inc. | 75 | 2021-07-08 | 2025-03-19 |
| Umbilical Cord Derived Mesenchymal Stem Cell (UC -MSC) Transplantation for Children Suffering From Biliary Atresia Umbilical Cord Derived Mesenchymal Stem Cell (UC -MSC) Transplantation - Primary Biliary Cirrhosis | Phase 1 / Phase 2 | Completed | Vinmec Research Institute of Stem Cell and Gene Technology | 20 | 2019-08-10 | 2024-06-06 |
| N-Acetylcysteine in Biliary Atresia After Kasai Portoenterostomy N-Acetyl cysteine - Biliary Atresia | Phase 2 | Completed | Baylor College of Medicine | 13 | 2018-05-18 | 2024-03-26 |
| Autologous Bone Marrow Mononuclear Stem Cell for Children Suffering From Liver Cirrhosis Due to Biliary Atresia Autologous BMMC transplantation - Liver Cirrhosis, Biliary | Phase 2 | Completed | Vinmec Research Institute of Stem Cell and Gene Technology | 17 | 2017-01-02 | 2024-06-04 |
| Safety Study of Intravenous Immunoglobulin (IVIG) Post-Portoenterostomy in Infants With Biliary Atresia Intravenous immunoglobulin (IVIG) - Biliary Atresia | Phase 1 / Phase 2 | Completed | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 30 | 2013-10-01 | 2026-10-01 |
Liver Cirrhosis (2) · Liver Cirrhosis, Biliary (2) · Bile Duct Diseases (1) · Biliary Tract Diseases (1) · Congenital Abnormalities (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (5) · Digestive System Abnormalities (5) · Digestive System Diseases (5) · Bile Duct Diseases (4) · Biliary Tract Diseases (4) · Congenital Abnormalities (4) · Cholestasis (2) · Cholestasis, Intrahepatic (2) · Fibrosis (2) · Liver Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2)
Acetylcysteine (1) · Hizentra (1) · Immunoglobulins, Intravenous (1) · Transplantation (1) · maralixibat (1)
Vinmec Research Institute of Stem Cell and Gene Technology (2) · Baylor College of Medicine (1) · Mirum Pharmaceuticals, Inc. (1) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)
United States (3) · Vietnam (3) · Canada (1) · China (1) · Germany (1) · Poland (1) · Singapore (1) · Taiwan (1) · United Kingdom (1)
Liem Nguyen (2) · Averell Sherker, MD (1) · Ed Doo, MD (1) · Ronald Sokol, MD (1) · Sanjiv Harpavat, MD. PhD (1)
PMID 30664564, PMID 35287722, PMID 40489761, PMID 40907882
U01DK062456 (1)